Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weon Kim

Showing results (641-650 of 710) with videos related to

Pageof 71
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03)Hyun Jin Lee, Seungbong Han, Young Seok Kim, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Chonnam Medical Journal|June 4, 2026
Clinical Outcomes and Use of Implantable Cardioverter-Defibrillator in Ischemic Heart Failure Patients with Reduced Ejection Fraction: A Retrospective Observational StudyKyung Hoon Cho, Ki Hong Lee, Yong-Kyu Lee, et al.
Cardiovascular Therapeutics|August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Cancers|August 7, 2021
Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in KoreaJune Young Chun, Se Ik Kim, Eun Young Park, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarctionYoung Joon Hong, Myung Ho Jeong, Dae Woo Hyun, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 27, 2005
Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary interventionSang Yup Lim, Myung Ho Jeong, Eun Hui Bae, et al.
Clinical Therapeutics|November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering EfficacyMoo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.
Coronary Artery Disease|December 4, 2018
Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trialDo-Yoon Kang, Cheol Hyun Lee, Pil Hyung Lee, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Pageof 71

Showing results (641-650 of 710) with videos related to

Sort By:
Pageof 71
International Journal of Radiation Oncology, Biology, Physics|October 22, 2013
Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03)Hyun Jin Lee, Seungbong Han, Young Seok Kim, et al.
Eclinicalmedicine|January 9, 2026
Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Chonnam Medical Journal|June 4, 2026
Clinical Outcomes and Use of Implantable Cardioverter-Defibrillator in Ischemic Heart Failure Patients with Reduced Ejection Fraction: A Retrospective Observational StudyKyung Hoon Cho, Ki Hong Lee, Yong-Kyu Lee, et al.
Cardiovascular Therapeutics|August 11, 2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)Kyung-Jin Kim, Sang-Hyun Kim, Young Won Yoon, et al.
Cancers|August 7, 2021
Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in KoreaJune Young Chun, Se Ik Kim, Eun Young Park, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarctionYoung Joon Hong, Myung Ho Jeong, Dae Woo Hyun, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 27, 2005
Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary interventionSang Yup Lim, Myung Ho Jeong, Eun Hui Bae, et al.
Clinical Therapeutics|November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering EfficacyMoo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.
Coronary Artery Disease|December 4, 2018
Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES VI trialDo-Yoon Kang, Cheol Hyun Lee, Pil Hyung Lee, et al.
Circulation|March 5, 2023
Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical TrialJung-Kyu Han, Doyeon Hwang, Seokhun Yang, et al.
Pageof 71